Prelude Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,000
Closed -$1.24M 1419
2025
Q2
$1.24M Buy
15,000
+986
+7% +$78.7K 0.12% 211
2025
Q1
$1.14M Buy
+14,014
New +$1.25M 0.11% 279
2024
Q4
Sell
-4,130
Closed -$408K 1625
2024
Q3
$408K Buy
+4,130
New +$406K 0.03% 711
2024
Q1
Sell
-3,440
Closed -$307K 1598
2023
Q4
$307K Buy
3,440
+294
+9% +$21.8K 0.03% 726
2023
Q3
$230K Buy
+3,146
New +$251K 0.02% 824
2022
Q4
Hold
0
1707
2022
Q3
Hold
0
2034
2022
Q2
Hold
0
2204
2022
Q1
Hold
0
2435
2021
Q4
Hold
0
2445
2021
Q3
Sell
-9,797
Closed -$1.33M 2184
2021
Q2
$1.33M Buy
+9,797
New +$1.29M 0.07% 465
2021
Q1
Hold
0
2025
2020
Q4
Hold
0
2285
2020
Q3
Hold
0
2646
2020
Q2
Hold
0
2509
2020
Q1
Hold
0
2320
2019
Q4
Hold
0
2468
2019
Q3
Hold
0
2271
2019
Q2
Hold
0
2330
2019
Q1
Hold
0
2354
2018
Q4
Hold
0
2300
2018
Q3
Hold
0
2166
2018
Q2
Hold
0
2046
2018
Q1
Hold
0
1796
2017
Q4
Hold
0
1814
2017
Q3
Hold
0
1997
2017
Q2
Hold
0
1939
2016
Q1
Hold
0
1589
2015
Q4
Hold
0
1746
2015
Q2
Sell
-6,300
Closed -$474K 2115
2015
Q1
$474K Buy
+6,300
New +$440K 0.07% 358

Other funds holding XBI